Douglas M Bennion Selected Research

Douglas M Bennion Research Topics

9	Stroke (Strokes) 01/2018 - 02/2014
8	Ischemic Stroke 01/2018 - 02/2014
3	Cerebral Infarction 01/2018 - 06/2014
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2018 - 06/2014
2	Hemorrhagic Stroke 02/2015 - 06/2014
1	Foreign Bodies (Foreign Body) 12/2021
1	Wounds and Injuries (Trauma) 12/2021
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Necrosis 01/2018
1	Infarction (Infarctions) 07/2015
1	Brain Ischemia (Cerebral Ischemia) 06/2014

4	Neuroprotective AgentsIBA 01/2018 - 02/2015
3	angiotensin I (1-7)IBA 01/2018 - 02/2014
3	Angiotensin IIIBA 01/2018 - 02/2014
3	compound 21IBA 01/2018 - 06/2014
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2018 - 02/2015
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2018 - 01/2018
2	Endothelin-1 (Endothelin 1)IBA 01/2018 - 06/2014
2	Type 2 Angiotensin ReceptorIBA 01/2017 - 06/2014
2	Angiotensin-Converting Enzyme 2IBA 07/2016 - 07/2015
2	Peptides (Polypeptides)IBA 06/2014 - 02/2014
1	HydrogelsIBA 12/2021
1	Biocompatible Materials (Biomaterials)IBA 12/2021
1	Oxygen (Dioxygen)IBA 01/2018
1	CyclodextrinsIBA 01/2018
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2018
1	CarboxypeptidasesIBA 07/2016
1	7-Ala-angiotensin (1-7)IBA 07/2015
1	diminazene aceturateIBA 07/2015
1	DiminazeneIBA 07/2015
1	2- (1- carboxy- 2- (3- (3,5- dichlorobenzyl)- 3H- imidazol- 4- yl)ethylamino)- 4- methylpentanoic acidIBA 07/2015
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 06/2014
1	CC ChemokinesIBA 06/2014
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2014
1	AngiotensinsIBA 02/2014
1	Therapeutic UsesIBA 02/2014
1	Collagenases (Collagenase)FDA Link 02/2014

4	Therapeutics 01/2018 - 07/2015
1	Electrodes (Electrode) 12/2021
1	Oral Administration 01/2018
1	Intraperitoneal Injections 01/2017